Advances in Personalized Photoprotection, Sunscreen Filters, and Biological Sun Protection

Conclusions

• Tinted sunscreens containing iron oxides are presented as the best U.S. option for protecting against both visible light and long-wave UVA-related pigment changes.
• Newer filters available in Europe and proposed for U.S. approval, especially bemotrizinol, may improve broad-spectrum protection by covering UVB, UVA, and long-wave UVA1 with better photostability and minimal absorption.
• Depigmenting agents and other non-filtering ingredients are emerging as useful add-ons to sunscreens to reduce pigmentary effects from sunlight, especially visible light and UVA1.
• Most non-filtering photoprotective ingredients have weak evidence, with only a small fraction supported by strong clinical data, so claims about them should be viewed cautiously.
• Among non-filtering photoprotective agents, vitamin C, niacinamide, green-tea polyphenols, vitamin E, thiamidol, N-acetylcysteine, photolyase, and Melasyl appear to be the most promising performers.
• Photoprotection should be personalized rather than one-size-fits-all, because skin type, microbiome, exposome, and genetics all influence how skin responds to UV and visible light.
• Light-skinned individuals generally need higher SPF for UVB protection, while darker-skinned individuals may still need meaningful UVA and visible-light protection to prevent pigmentation changes.
• Visible-light protection is especially important for darker skin types, but current regulatory systems do not yet provide a standard way to rate sunscreen performance in this range.
• The overall message is that effective photoprotection requires a balanced, individualized combination of shade, clothing, sunscreen choice, and other protective strategies.
• The field is moving toward broader and more biologically informed photoprotection, but patient counseling should remain evidence-based and realistic until stronger data are available.